60
Participants
Start Date
July 31, 2011
Primary Completion Date
February 28, 2018
Study Completion Date
March 31, 2018
Pregabalin
"drug form : capsule, 75/150mg. Pregabalin will be provided to treatment arm subjects for 6-week Treatment period.~Treatment period : 75 mg twice daily during the first 1 week as titration + 150mg twice daily for 4 weeks as maintenance + 75mg twice a day as tapering"
Placebo
"drug form : capsule, 75/150mg. Pregabalin will be provided to treatment arm subjects for 6-week Treatment period.~Treatment period : 75 mg twice daily during the first 1 week as titration + 150mg twice daily for 4 weeks as maintenance + 75mg twice a day as tapering"
Seoul Metropolitan Government Boramae Medical Center, Seoul
Collaborators (1)
Pfizer
INDUSTRY
Seoul National University Boramae Hospital
OTHER